Abiopharma

BXP, Inc. is a fully integrated, self-administered and self-managed real estate investment trust. The Company develops, owns and manages premier workplaces in the United States. The Companys segments by geographic area are Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. Its segment by property type includes Office (which includes office, life sciences and retail), Residential, and Hotel. Its portfolio totals 53.0 million square feet and 184 properties, including nine properties under construction/redevelopment. Its properties consist of 162 office and life sciences properties (including seven properties under construction/redevelopment); 14 retail properties (including one property under construction); seven residential properties (including two properties under construction), and one hotel. Its properties include Times Square Tower, 100 Federal Street, 767 Fifth Avenue, 601 Lexington Avenue, Atlantic Wharf Office Building, 343 Madison Avenue, and others.

Additional info from NASDAQ:
BXP, Inc. is a fully integrated, self-administered and self-managed real estate investment trust. The Company develops, owns and manages premier workplaces in the United States. The Companys segments by geographic area are Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. Its segment by property type includes Office (which includes office, life sciences and retail), Residential, and Hotel. Its portfolio totals 53.0 million square feet and 184 properties, including nine properties under construction/redevelopment. Its properties consist of 162 office and life sciences properties (including seven properties under construction/redevelopment); 14 retail properties (including one property under construction); seven residential properties (including two properties under construction), and one hotel. Its properties include Times Square Tower, 100 Federal Street, 767 Fifth Avenue, 601 Lexington Avenue, Atlantic Wharf Office Building, 343 Madison Avenue, and others.